Combination Therapy in Hypertension with Diabetes: Preferential Consideration for CCB and ARBs Dr. Pramila Kalra4 Jan 2021 7:15 AM GMTThe last edition of the International Diabetes Federation (IDF) Atlas offered projections that continue to put India at the second slot in the...
Vitamin K2 supplementation lowers risk in Type 2 Diabetes Mellitus: Review Meghna A Singhania2 Jan 2021 7:15 AM GMTStudies on Vitamin K2 have witnessed a boom in the last few years owing to its multitude of beneficial effect on cardiovascular risk and vascular...
Avoiding Aldosterone Breakthrough in Hypertensive Diabetics: Role of Azelnidipine Dr. Prem Aggarwal28 Dec 2020 7:00 AM GMTAzelnidipine may contribute to avoid the 'aldosterone breakthrough' by its suppressive effects on aldosterone synthesis and secretion
Impact of Azelnidipine in reducing urinary albumin excretion and carotid atherosclerosis in type 2 diabetes patients: BOAT 2 study Review Dr. Prem Aggarwal15 Dec 2020 7:15 AM GMTHypertension and Diabetes Mellitus are the global health burden and strong risk factors for coronary artery disease (1). Impaired glucose tolerance...
Azelnidipine versus Amlodipine in hypertensive diabetics with albuminuria: Review Dr. Prem Aggarwal27 Nov 2020 7:15 AM GMTHypertension is common among diabetics and those who have chronic kidney disease. Both hypertension and diabetes are associated with increased...
Hypertension in Diabetes: Considering Therapies which Optimise Kidney Protection Dr Sujoy Ghosh20 Nov 2020 5:55 AM GMTHypertension and Diabetes remain the top two causes of End-Stage Renal Disease (ESRD) (1). Hence, it seems clinically appropriate to establish that...
Role of Azelnidipine on management of BP in hypertensive Diabetics: Review Dr. Prem Aggarwal4 Nov 2020 5:39 AM GMTHypertensive patients with type 2 diabetes carry a high cardiovascular risk. Most patients with hypertension and diabetes face higher mortality due to ...
BPLTTC: Using Antihypertensive agents as risk modifiers for prevention of CV events irrespective of baseline criteria: Scope of Amlodipine Dr. Prem Aggarwal13 Oct 2020 6:47 AM GMTHypertension, a prominent cause of premature mortality, affects ~1.13 billion people worldwide, though blood pressure (BP) control rates remain dismal ...
Gliclazide modified release better second-line treatment than sitagliptin for type 2 diabetes patients on Metformin- Study Hina Zahid9 Oct 2020 4:14 AM GMTUK: Gliclazide modified release (MR) is more effective in reducing blood sugar levels than sitagliptin in type 2 diabetes (T2D) patients already...
